GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dimerix Ltd (OTCPK:SBMJF) » Definitions » Other Stockholders Equity

SBMJF (Dimerix) Other Stockholders Equity : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Dimerix Other Stockholders Equity?

Dimerix's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $0.00 Mil.

Dimerix's quarterly Other Stockholders Equity increased from Dec. 2023 ($-0.00 Mil) to Jun. 2024 ($0.00 Mil) and increased from Jun. 2024 ($0.00 Mil) to Dec. 2024 ($0.00 Mil).

Dimerix's annual Other Stockholders Equity declined from Jun. 2022 ($0.00 Mil) to Jun. 2023 ($-0.00 Mil) but then increased from Jun. 2023 ($-0.00 Mil) to Jun. 2024 ($0.00 Mil).


Dimerix Other Stockholders Equity Historical Data

The historical data trend for Dimerix's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimerix Other Stockholders Equity Chart

Dimerix Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dimerix Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Dimerix Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Dimerix Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Dimerix's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Dimerix Business Description

Traded in Other Exchanges
Address
425 Smith Street, Fitzroy, VIC, AUS, 3065
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Dimerix Headlines

From GuruFocus

DIMERIX's DMX-200 Posts Strong Results in Kidney Disease Trial

By Business Wire Business Wire 07-29-2020